Keyphrases
5-year Survival
33%
Adult Patients
33%
Bleomycin
33%
Burden Test
100%
Chemotherapy
33%
Clinical Factors
33%
Clinical Outcomes
33%
Complete Remission
33%
Cyclophosphamide
33%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Disease-free
33%
Doxorubicin
33%
Independent Risk Factors
33%
Lactic Dehydrogenase
66%
Overall Survival
33%
Patient Risk
33%
Prednisone
33%
Previously Untreated
33%
Prognostic Factors
33%
Prognostic Model
100%
Proportional Hazards Model
33%
Radiation Therapy
33%
Relapse-free Survival
33%
Remission
33%
Risk Factors for Survival
33%
Treatment Assessment
33%
Treatment Programs
33%
Treatment Regimen
33%
Tumor Burden
100%
Working Diagnosis
33%
Medicine and Dentistry
Bleomycin
33%
Cyclophosphamide
33%
Diseases
33%
Doxorubicin
33%
High Risk Population
33%
Lactate Dehydrogenase
66%
Large-Cell Lymphoma
100%
Neoplasm
100%
Overall Survival
33%
Prednisone
33%
Prognostic Factor
33%
Prognostic Model
100%
Proportional Hazards Model
33%
Radiation Therapy
33%
Recurrence Free Survival
33%
Survival Rate
33%
Vincristine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin
33%
Chemotherapy
33%
Cyclophosphamide
33%
Diseases
33%
Doxorubicin
33%
Lactate Dehydrogenase
66%
Large Cell Lymphoma
100%
Neoplasm
100%
Overall Survival
33%
Prednisone
33%
Recurrence Free Survival
33%
Remission
66%
Survival Rate
33%
Vincristine
33%